Interprofessional Pharmacokinetics Simulation: Pharmacy and Nursing Students' Perceptions
Cheryl D Cropp1, Jennifer Beall2, Ellen Buckner3
1McWhorter School of Pharmacy, Samford University, 800 Lakeshore Drive, Birmingham, AL 35229, USA. ccropp@samford.edu.
Pharmacy (Basel, Switzerland)
|July 25, 2018
Summary
This study explored nursing and pharmacy students' perceptions of an interprofessional pharmacokinetics simulation. The simulation effectively enhanced student learning and collaboration skills, aligning with core competencies.
Area of Science:
- Health Professions Education
- Interprofessional Education
- Simulation-Based Learning
Background:
- Interprofessional practice between pharmacists and nurses is crucial for medication management in hospitals.
- Pharmacokinetic dosing requires collaboration for safe and effective patient care.
- Limited research exists on student perceptions of interprofessional education (IPE) in clinical simulations.
Purpose of the Study:
- To describe student perceptions of an interprofessional collaboration pharmacokinetics simulation.
- To evaluate the simulation's alignment with the Interprofessional Education Collaborative (IPEC) 2016 Core Competencies.
- To explore student experiences with interprofessional learning in a simulated clinical context.
Main Methods:
- A simulation activity was developed for senior undergraduate nursing and second-year pharmacy students.
- Participants (n=54 nursing, n=91 pharmacy) used medium-fidelity manikins for pharmacokinetic dosing cases.
- Student communication followed the SBAR (Situation, Background, Assessment, and Recommendation) framework, followed by debriefing and surveys.
Main Results:
- Survey themes indicated positive student perceptions across all IPEC competencies.
- Students reported meaningful learning, safety, advocacy, and appreciation, alongside areas for improvement.
- The simulation experience was perceived as effective for learning.
Conclusions:
- Interprofessional pharmacokinetics simulations provide valuable learning experiences for nursing and pharmacy students.
- This simulation positively impacted student perceptions of interprofessional collaboration and patient safety.
- Further exploration of IPE in clinical contexts through simulation is warranted.
Related Concept Videos
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:06Three-Compartment Open Model
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).